ATE327743T1 - Sertralin zur behandlung der sozialen phobie - Google Patents

Sertralin zur behandlung der sozialen phobie

Info

Publication number: ATE327743T1
Authority: AT; Austria
Prior art keywords: social phobia; sertraline; treatment; naphthalenamine; dichlorophenyl
Prior art date: 1989-11-02

Application number

AT01103959T

Other languages

English (en)

Inventor

Declan P Doogan

Karen A Scappaticci

Elizabeth Hackett

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-02

Filing date

1990-10-29

Publication date

2006-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23710001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE327743(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-10-29 Application filed by Pfizer filed Critical Pfizer

2006-06-15 Application granted granted Critical

2006-06-15 Publication of ATE327743T1 publication Critical patent/ATE327743T1/de

Links

206010041250 Social phobia Diseases 0.000 title abstract 2
VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title abstract 2
229960002073 sertraline Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Anesthesiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT01103959T 1989-11-02 1990-10-29 Sertralin zur behandlung der sozialen phobie ATE327743T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/431,000 US4962128A (en)	1989-11-02	1989-11-02	Method of treating anxiety-related disorders using sertraline

Publications (1)

Publication Number	Publication Date
ATE327743T1 true ATE327743T1 (de)	2006-06-15

Family

ID=23710001

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AT90311797T ATE212223T1 (de)	1989-11-02	1990-10-29	Verwendung von sertraline zur herstellung eines arzneimittels zur behandlung von obsessiv- kompulsiven erkrankungen
AT01103962T ATE269068T1 (de)	1989-11-02	1990-10-29	Verwendung von sertralin zur behandlung von posttraumatischen stresserkrankungen
AT01103959T ATE327743T1 (de)	1989-11-02	1990-10-29	Sertralin zur behandlung der sozialen phobie

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
AT90311797T ATE212223T1 (de)	1989-11-02	1990-10-29	Verwendung von sertraline zur herstellung eines arzneimittels zur behandlung von obsessiv- kompulsiven erkrankungen
AT01103962T ATE269068T1 (de)	1989-11-02	1990-10-29	Verwendung von sertralin zur behandlung von posttraumatischen stresserkrankungen

Country Status (17)

Country	Link
US (1)	US4962128A (de)
EP (4)	EP1129708B1 (de)
JP (1)	JPH03153624A (de)
KR (1)	KR960016580B1 (de)
AT (3)	ATE212223T1 (de)
AU (1)	AU616127B2 (de)
CA (1)	CA2029065C (de)
DE (3)	DE69034149T2 (de)
DK (3)	DK1129708T3 (de)
HU (1)	HUT59305A (de)
IE (4)	IE20020409A1 (de)
IL (1)	IL96146A (de)
MY (1)	MY106075A (de)
NZ (1)	NZ235933A (de)
PH (1)	PH26836A (de)
PT (1)	PT95760B (de)
ZA (1)	ZA908768B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4940731A (en) *	1989-08-30	1990-07-10	Pfizer Inc.	Method of treating premature ejaculation using sertraline
DE69004529T2 (de) *	1989-08-30	1994-02-24	Pfizer	Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
IE912826A1 (en) *	1990-08-09	1992-02-12	Massachusetts Inst Technology	Method for treating the premenstrual or late luteal phase¹syndrome
US5457100A (en) *	1991-12-02	1995-10-10	Daniel; David G.	Method for treatment of recurrent paroxysmal neuropsychiatric
US5597826A (en)	1994-09-14	1997-01-28	Pfizer Inc.	Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
US5525347A (en) *	1995-01-31	1996-06-11	Medical University Of South Carolina	Composition and methods for treating performance anxiety
AU761618B2 (en) *	1997-07-01	2003-06-05	Pfizer Inc.	Sertraline salts and sustained-release dosage forms of sertraline
US20030133974A1 (en) *	1997-07-01	2003-07-17	Curatolo William John	Encapsulated solution dosage forms of sertraline
US20040208926A1 (en) *	1997-07-01	2004-10-21	Pfizer Inc	Solubilized sertraline compositions
IL133080A0 (en)	1997-07-01	2001-03-19	Pfizer	Sertraline salts and sustained-release dosage forms of sertraline
US6391922B1 (en)	1998-01-13	2002-05-21	Synchroneuron, Llc	Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
DE19830201A1 (de) *	1998-07-07	2000-01-13	Boehringer Ingelheim Pharma	Mittel mit antidepressiver Wirkung
US6727283B2 (en) *	1998-10-13	2004-04-27	Pfizer Inc.	Sertraline oral concentrate
UA72743C2 (en) *	1998-10-13	2005-04-15	Pfizer Prod Inc	Essentially nonaqueous liquid pharmaceutical concentrate composition containing sertraline, method of using this concentrate, method for treatment
IL132500A0 (en)	1998-10-29	2001-03-19	Pfizer Prod Inc	Stereoselective microbial reduction of a racemic tetralone
US6245782B1 (en)	1999-05-17	2001-06-12	Heartdrug Research L.L.C.	Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
AR021155A1 (es) *	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
WO2001047498A2 (en)	1999-12-23	2001-07-05	Pfizer Products Inc.	Hydrogel-driven layered drug dosage form comprising sertraline
CA2445843A1 (en) *	2001-05-01	2002-11-07	H. Lundbeck A/S	The use of enantiomeric pure escitalopram
US20030119908A1 (en) *	2001-12-21	2003-06-26	Zambon Group S.P.A.	Stable gabapentin compositions
EP2316468A1 (de)	2002-02-22	2011-05-04	Shire LLC	Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Dextroamphetamin
US20040131672A1 (en) *	2003-01-07	2004-07-08	Nilobon Podhipleux	Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
US20050070577A1 (en) *	2003-07-03	2005-03-31	Pfizer Inc.	Compositions containing a serotonin selective reuptake inhibitor and a 5-HT2A receptor antagonist
EP1737473A4 (de) *	2004-04-19	2009-08-26	Noven Therapeutics Llc	Lithium-kombinationen und relevante verwendungen
BRPI0509592A (pt) *	2004-05-06	2007-09-25	Cydex Inc	formulações de sabor mascarado, contendo sertralina e ciclodextrina de éter de sulfoalquila
US7893053B2 (en) *	2006-06-16	2011-02-22	Theracos, Inc.	Treating psychological conditions using muscarinic receptor M1 antagonists
US20060257475A1 (en) *	2006-08-17	2006-11-16	Boehringer Ingelheim International Gmbh	Stable Sertraline Hydrochloride Formulation and Method
GB0708818D0 (en) *	2007-05-08	2007-06-13	Portela & Ca Sa	Compounds
WO2010094074A1 (en) *	2009-02-20	2010-08-26	Palmaya Pty Ltd	Pharmaceutical preparation and delivery system
US20100298397A1 (en) *	2009-05-19	2010-11-25	Singh Nikhilesh N	Method of treatment of obsessive compulsive disorder with ondansetron
EP2875810A1 (de) *	2013-11-20	2015-05-27	Biocodex	Pharmakologische Behandlung von Zwangsstörungen unter Verwendung von Stiripentol oder einer ähnlichen Verbindung
GB2630572A (en)	2023-05-29	2024-12-04	Novumgen Ltd	An orally disintegrating tablet of sertraline and its process of preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4536518A (en) *	1979-11-01	1985-08-20	Pfizer Inc.	Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
JP2938463B2 (ja) *	1987-10-22	1999-08-23	マサチユセツツ・インスチチユート・オブ・テクノロジー	月経前又は後期黄体期症候群の処置
IL91398A (en) *	1988-08-30	1994-05-30	Pfizer	Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane

1989
- 1989-11-02 US US07/431,000 patent/US4962128A/en not_active Expired - Lifetime
1990
- 1990-10-28 IL IL9614690A patent/IL96146A/en not_active IP Right Cessation
- 1990-10-29 AT AT90311797T patent/ATE212223T1/de not_active IP Right Cessation
- 1990-10-29 EP EP01103959A patent/EP1129708B1/de not_active Revoked
- 1990-10-29 DE DE69034149T patent/DE69034149T2/de not_active Revoked
- 1990-10-29 DK DK01103959T patent/DK1129708T3/da active
- 1990-10-29 EP EP90311797A patent/EP0429189B1/de not_active Revoked
- 1990-10-29 DK DK90311797T patent/DK0429189T3/da active
- 1990-10-29 DK DK01103962T patent/DK1127571T3/da active
- 1990-10-29 AT AT01103962T patent/ATE269068T1/de not_active IP Right Cessation
- 1990-10-29 EP EP01103963A patent/EP1125581A1/de not_active Ceased
- 1990-10-29 DE DE69033903T patent/DE69033903D1/de not_active Revoked
- 1990-10-29 DE DE69034223T patent/DE69034223T2/de not_active Revoked
- 1990-10-29 AT AT01103959T patent/ATE327743T1/de not_active IP Right Cessation
- 1990-10-29 PH PH41458A patent/PH26836A/en unknown
- 1990-10-29 EP EP01103962A patent/EP1127571B1/de not_active Revoked
- 1990-10-31 CA CA002029065A patent/CA2029065C/en not_active Expired - Lifetime
- 1990-10-31 JP JP2295130A patent/JPH03153624A/ja active Pending
- 1990-10-31 PT PT95760A patent/PT95760B/pt not_active IP Right Cessation
- 1990-11-01 ZA ZA908768A patent/ZA908768B/xx unknown
- 1990-11-01 KR KR1019900017691A patent/KR960016580B1/ko not_active Expired - Fee Related
- 1990-11-01 IE IE20020409A patent/IE20020409A1/en unknown
- 1990-11-01 NZ NZ235933A patent/NZ235933A/en unknown
- 1990-11-01 IE IE393690A patent/IE903936A1/en not_active IP Right Cessation
- 1990-11-01 AU AU65715/90A patent/AU616127B2/en not_active Ceased
- 1990-11-01 MY MYPI90001915A patent/MY106075A/en unknown
- 1990-11-01 IE IE20020410A patent/IE20020410A1/en not_active IP Right Cessation
- 1990-11-01 IE IE20020411A patent/IE20020411A1/en unknown
- 1990-11-02 HU HU907011A patent/HUT59305A/hu unknown

Also Published As

Publication number	Publication date
IE20020411A1 (en)	2002-11-27
EP1127571B1 (de)	2004-06-16
DE69034149D1 (de)	2004-07-22
NZ235933A (en)	1997-07-27
EP0429189B1 (de)	2002-01-23
DE69034149T2 (de)	2004-09-30
DK1127571T3 (da)	2004-09-20
DE69033903D1 (de)	2002-03-14
AU6571590A (en)	1991-08-01
KR960016580B1 (ko)	1996-12-16
DE69034223T2 (de)	2006-11-02
EP1129708B1 (de)	2006-05-31
MY106075A (en)	1995-03-31
IE903936A1 (en)	1991-05-08
DE69034223D1 (de)	2006-07-06
CA2029065A1 (en)	1991-05-03
ZA908768B (en)	1992-06-24
PT95760A (pt)	1991-09-13
ATE269068T1 (de)	2004-07-15
IL96146A0 (en)	1991-07-18
DK1129708T3 (da)	2006-08-07
EP0429189A3 (en)	1992-01-22
KR910009252A (ko)	1991-06-28
HU907011D0 (en)	1991-05-28
IE20020409A1 (en)	2002-11-27
CA2029065C (en)	1994-11-08
EP0429189A2 (de)	1991-05-29
HUT59305A (en)	1992-05-28
IE20020410A1 (en)	2002-11-27
IL96146A (en)	1995-10-31
US4962128A (en)	1990-10-09
PH26836A (en)	1992-11-05
JPH03153624A (ja)	1991-07-01
EP1129708A1 (de)	2001-09-05
EP1127571A1 (de)	2001-08-29
ATE212223T1 (de)	2002-02-15
AU616127B2 (en)	1991-10-17
EP1125581A1 (de)	2001-08-22
DK0429189T3 (da)	2002-02-11
PT95760B (pt)	1997-12-31

Legal Events

Date

Code

Title

Description

2007-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1129708

Country of ref document: EP

2009-07-15

REN

Ceased due to non-payment of the annual fee

2009-08-15

RZN

Patent revoked

Publication	Publication Date	Title
DE69034223D1 (de)	2006-07-06	Sertralin zur Behandlung der sozialen Phobie
AU609664B1 (en)	1991-05-02	A method of treating premature ejaculation using sertraline
KR880012218A (ko)	1988-11-26	캘폰 유도체를 사용한 다발성 경화증의 치료방법
DE236684T1 (de)	1988-04-28	Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE69400799D1 (de)	1996-11-28	Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
IL128723A0 (en)	2000-01-31	Pharmaceutical compositions containing rar antagonists and rxr agonists
DE69626916D1 (de)	2003-04-30	Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten
AU617622B2 (en)	1991-11-28	A method of treating chemical dependencies using sertraline
ATE222768T1 (de)	2002-09-15	Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
ATE80998T1 (de)	1992-10-15	Verwendung von nalmefen zur herstellung eines arzneimittels zur behandlung der schaedigung des zentralnervensystems.
EP0760013A4 (de)	1997-12-10	Behandlung von influenzavirusinfektion mittels antivirale verbindungen, welche die acylierung/palmitylierung von hemagglutinin inhibieren
ES2093515T3 (es)	1996-12-16	Aplicacion del riluzol como radio-restaurador.